N-Dodecyl vinyl ether (CAS 765-14-0)
Lauryl vinyl ether
CAS 765-14-0 · C14H28O · MW 212.37 g/mol
Molekül wird geladen...
Wissenschaftliche Literatur
Related literature
11 artykułów · 8 open access · Źródła: PubMed, OpenAlex, Semantic Scholar
📈 Timeline publikacji (11 artykułów)
Wysokość słupka = liczba artykułów w roku. Hover dla szczegółów.
A. Lafarge, T. Dupont, E. Canet et al. (2024) · American Journal of Respiratory and Critical Care Medicine
AI Summary
Most critically ill Allo-HSCT recipients survive their ICU stay, including those requiring mechanical ventilation, with an overall day-90 survival rate reaching 51.8%.
Most critically ill Allo-HSCT recipients survive their ICU stay, including those requiring mechanical ventilation, with an overall day-90 survival rate reaching 51.8%.
Guy Rostoker, Jean-Jacques Dumas, Benoît Thomé et al. (2025) · European journal of internal medicine
AI Summary
Daily home haemodialysis is a more cost-effective and patient-centred treatment option than in-centre HD.
Daily home haemodialysis is a more cost-effective and patient-centred treatment option than in-centre HD.
Qianqian Guo, Q. An, Lin Zhao et al. (2023) · Journal of Clinical Medicine
Francis Xavier Kasujja, Faith Aikaeli, A. Garrib et al. (2026) · The Lancet
AI Summary
This open-label, multicountry, cluster-randomised trial was conducted in 14 primary care facilities across Tanzania and Uganda to compare integrated community-based care with integrated facility-based care for people with HIV, diabetes, and hypertension.
This open-label, multicountry, cluster-randomised trial was conducted in 14 primary care facilities across Tanzania and Uganda to compare integrated community-based care with integrated facility-based care for people with HIV, diabetes, and hypertension.
Xiaohan Ma, Xin Tang, Sheng Chen et al. (2025) · BMC Cardiovascular Disorders
AI Summary
ALI is an effective prognostic predictor of mortality risk in individuals with CKM syndrome and is negatively correlated with all-cause, cardio-cerebrovascular, and cancer mortality within a certain range in patients with CKM syndrome.
ALI is an effective prognostic predictor of mortality risk in individuals with CKM syndrome and is negatively correlated with all-cause, cardio-cerebrovascular, and cancer mortality within a certain range in patients with CKM syndrome.
James Whitworth, Valerie Ya Wen Wang, Daniella Black et al. (2026) · The Lancet Oncology
AI Summary
The analysis highlights the implications of more expansive genetic testing and the variant interpretation considerations necessary to yield benefit and avoid harm (eg, unnecessary surveillance) for patients.
The analysis highlights the implications of more expansive genetic testing and the variant interpretation considerations necessary to yield benefit and avoid harm (eg, unnecessary surveillance) for patients.
P. Kulkarni, Khalequ Zaman, S. Desai et al. (2025) · Lancet. Infectious Diseases (Print)
AI Summary
This double-blind, randomised, controlled, phase 3 study aimed to compare the safety and immunogenicity of a dose-sparing IPV (ds-IPV) with a full-dose IPV in infants in Bangladesh.
This double-blind, randomised, controlled, phase 3 study aimed to compare the safety and immunogenicity of a dose-sparing IPV (ds-IPV) with a full-dose IPV in infants in Bangladesh.
A. Harimanana, Dina Ny Aina Liantsoa Randriamiarinjatovo, Tovonanahary Angelo Rakotomanga et al. (2025) · American Journal of Tropical Medicine and Hygiene
AI Summary
The study results reveal that ASAQ and AL remain safe and efficacious for treating uncomplicated P. falciparum malaria in Madagascar.
The study results reveal that ASAQ and AL remain safe and efficacious for treating uncomplicated P. falciparum malaria in Madagascar.
P. de Zoysa, S. Weerasinghe, J. Gamage et al. (2026) · Trials
AI Summary
This clinical trial is to determine the impact of an electronic clinical decision support tool (eCDST) on LRTI management in Southern Sri Lanka and the impact of the RespiQuestAB on antibacterial use and clinical outcomes among patients with LRTI in an LMIC setting.
This clinical trial is to determine the impact of an electronic clinical decision support tool (eCDST) on LRTI management in Southern Sri Lanka and the impact of the RespiQuestAB on antibacterial use and clinical outcomes among patients with LRTI in an LMIC setting.
Jose A. Soto, H. Cemin, Morgan D. Hart et al. (2026) · Journal of Animal Science
Dane z PubMed (NIH NLM), OpenAlex (CC0), Semantic Scholar (AI2). AI Summary wygenerowane przez Semantic Scholar TLDR. Artykuły z ikoną 
wymagają płatnego dostępu.